Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Government Administration Activities

Marinus Pharmaceuticals
Regional

Marinus Pharmaceuticals Gains Approval for Seizure Drug in China

July 23, 2024July 22, 2024 - by Timothy Alexander

RADNOR, PA — Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS) has announced that China’s National Medical Products Administration (NMPA) has approved its ganaxolone oral suspension. This drug targets epileptic seizures in patients …

Marinus Pharmaceuticals Gains Approval for Seizure Drug in China Read More

Passage Bio
Health / Medical / Regional

Passage Bio Receives FDA Support for Expanding Dementia Treatment Trial

July 17, 2024July 16, 2024 - by Timothy Alexander

PHILADELPHIA, PA — Passage Bio, Inc. (NASDAQ: PASG) announced positive feedback from the U.S. Food and Drug Administration (FDA) on its proposal to evaluate PBFT02 for treating frontotemporal dementia (FTD) …

Passage Bio Receives FDA Support for Expanding Dementia Treatment Trial Read More
INOVIO Pharmaceuticals
Regional

INOVIO’s DNA Medicine INO-3107 Receives U.K. Innovation Passport

July 15, 2024July 14, 2024 - by Timothy Alexander

PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) announced that its lead DNA medicine candidate, INO-3107, has been granted an Innovation Passport by the U.K.’s Innovative Licensing and Access Pathway (ILAP). …

INOVIO’s DNA Medicine INO-3107 Receives U.K. Innovation Passport Read More

Cat
National

FDA Approves First Generic Methimazole Oral Solution for Cats

July 14, 2024July 14, 2024 - by Maryann Pugh

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved Felanorm, the first generic methimazole oral solution for treating hyperthyroidism in cats. This new medication offers a vital …

FDA Approves First Generic Methimazole Oral Solution for Cats Read More
United States Department of Labor
National / Social Services

U.S. Department of Labor Awards $56 Million to Aid Reentry for Formerly Incarcerated Individuals

July 8, 2024July 8, 2024 - by Maryann Pugh

WASHINGTON, D.C. — The U.S. Department of Labor announced the award of more than $56 million in grants aimed at reducing recidivism and assisting individuals re-entering their communities after incarceration. …

U.S. Department of Labor Awards $56 Million to Aid Reentry for Formerly Incarcerated Individuals Read More

Technology
National / Technology

U.S. Commerce Department Awards $504 Million to Boost Tech Hubs Nationwide

July 8, 2024July 8, 2024 - by Maryann Pugh

WASHINGTON, D.C. — The U.S. Department of Commerce’s Economic Development Administration (EDA) recently announced a new round of funding totaling approximately $504 million. These implementation grants aim to scale up …

U.S. Commerce Department Awards $504 Million to Boost Tech Hubs Nationwide Read More
Diamond Shruumz-brand products
National

FDA Warns Against Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies Amid Illness Outbreak

June 23, 2024June 23, 2024 - by Maryann Pugh

WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently updated its advisory regarding illnesses linked to Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies. As of June 17, 2024, …

FDA Warns Against Diamond Shruumz-brand Chocolate Bars, Cones, and Gummies Amid Illness Outbreak Read More

FDA
Health / Medical / National

FDA Broadens Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy Patients

June 22, 2024June 21, 2024 - by Maryann Pugh

WASHINGTON, D.C. — This week, in a significant step for the medical world and hope for patients, the U.S. Food and Drug Administration expanded the approval of Elevidys, a gene …

FDA Broadens Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy Patients Read More
Medical news
Cancer / National

FDA Approves Keytruda Combination for Advanced Endometrial Cancer

June 20, 2024June 20, 2024 - by Maryann Pugh

WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with carboplatin and paclitaxel, followed by single-agent pembrolizumab, for adult patients with primary …

FDA Approves Keytruda Combination for Advanced Endometrial Cancer Read More
U.S. Food and Drug Administration (FDA)
Cancer / National

FDA Approves New Treatment for Advanced Endometrial Cancer

June 20, 2024June 19, 2024 - by Maryann Pugh

WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved durvalumab (Imfinzi, AstraZeneca UK Limited) for use with carboplatin plus paclitaxel followed by single-agent durvalumab. This approval targets …

FDA Approves New Treatment for Advanced Endometrial Cancer Read More

Posts pagination

Previous 1 … 12 13 14 15 Next

Trending News

  • Health Inspectors Flag Food Safety Lapses Across Chester County Eateries

  • West Pharma Declares Dividend as Exton Giant Signals Steady Footing

  • Take Control: Why Budgeting Doesn’t Have to Feel Restrictive

  • New Gateway, New Vision: Cecil College Opens Facilities Building, Honors Pioneer

  • Red Kettles Face Countdown Crunch as Salvation Army Sounds Holiday Alarm

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Salvation Army

Red Kettles Face Countdown Crunch as Salvation Army Sounds Holiday Alarm

December 18, 2025December 17, 2025

Christopher Smith

Burglary Scare Grips Newark Townhomes as Police Arrest Suspect

December 17, 2025December 17, 2025

Theft suspects

Stolen Cards, Gift Card Trail: Police Seek Suspect in New Castle Theft Case

December 17, 2025December 17, 2025

Copyright © 2025 MyChesCo.